Peptide Shipping Regulations for U.S. Research Labs

No single federal rule governs the shipping of research peptides. Several regimes apply at once: FDA and Customs and Border Protection (CBP) rules for anything crossing the border, Department of Transportation hazardous materials rules for packaging and refrigerants such as dry ice, and the contract terms of the carrier that moves the parcel. This guide explains how those layers fit together for domestic laboratory shipments, what documentation a receiving lab should expect, and where a research-use-only (RUO) label stops providing any protection.

For Research Use Only. Not for human or veterinary use. This article is general information for laboratory personnel, not legal advice. Confirm specific shipments with your institution’s compliance office, a licensed customs broker, or your carrier’s dangerous goods desk.

Vertex Labs

Research Peptides With Traceable Testing

Vertex Labs supplies research-use-only peptides with independent third-party testing and batch-specific Certificates of Analysis for laboratory research.

Visit Vertex Labs

TL;DR

Domestic and import shipments are judged by several agencies at once. An RUO label is one input among many, not an exemption.
FDA states that materials used only for basic research or clinical laboratory testing are not regulated by FDA when imported, but the importer and broker must handle the disclaimer correctly.
Dry ice and any material classed as a regulated biological substance bring 49 CFR packaging, marking, and carrier-contract requirements.
Keep a batch-specific Certificate of Analysis (COA), an accurate commodity description, and a written statement of research purpose with every shipment record.
Regulators read a supplier’s website, product bundles, and customer messaging, not only the vial label.

Which rules apply to a peptide shipment
What FDA says about research-use shipments
Imports: CBP, classification, and enforcement
Packaging requirements that regulators actually specify
Dry ice and temperature-controlled shipments
Carrier terms: the contract layer
Documentation a receiving lab should expect and keep
Red flags in supplier shipping practices
Our perspective
Ordering for your laboratory
FAQ
Sources

Which rules apply to a peptide shipment

It helps to separate four questions, because each is answered by a different body.

Question	Who answers it	What it governs
Is the material a drug, device, or biological product under federal law?	FDA	Whether the product is treated as an unapproved new drug or as a research material
Can it enter the country?	CBP and partner agencies	Classification, labeling, manifest, admissibility
How must the package be built and marked?	DOT / PHMSA	Packaging, marking, refrigerants, hazard classification
Will the carrier accept and deliver it?	The carrier’s own terms	Prohibited items, perishable goods, liability, dangerous goods contracts

A shipment can satisfy one layer and fail another. A well-packed parcel with an accurate invoice can still be a problem if the seller’s marketing signals human use. Conversely, a compliant seller can lose a parcel to a packaging failure.

What FDA says about research-use shipments

FDA’s import guidance for research materials is narrower than many buyers assume. Biological specimens used only for testing in a clinical laboratory or for basic scientific research are not regulated by FDA when they are not intended to prevent, treat, diagnose, or cure disease. The same page tells importers to work with their broker to disclaim FDA jurisdiction properly, and only where the tariff code permits it.

Two points follow from that wording.

The exemption depends on intended use, not on a stamp on the label. If the intended use is anything other than research, the premise fails.
The disclaimer is a procedural step with a correct code behind it. Our guide on COAs and CAS records and how they shape peptide HS codes covers how documentation supports classification.

Why the RUO label is not a shield

FDA has said plainly that labeling does not settle the question. In a warning letter issued in March 2026, the agency treated a peptide seller’s products as unapproved new drugs based on how they were marketed, citing sections 301(d) and 505(a) of the FD&C Act. The reasoning is evidence-based: regulators weigh website content, product bundles such as pairing peptides with sterile water, and customer messaging together.

That matters for shipping because the shipment is the point at which intent becomes visible. An invoice, a packing list, and a web page describing the same product all tell the same story or a conflicting one. For a deeper look at how claims and bundles can pull research-labeled products into drug regulation, this checklist for U.S. researchers is a useful outside reference, and our own piece on research peptide rules and RUO risk walks through the enforcement pattern.

Imports: CBP, classification, and enforcement

If a peptide shipment originates outside the United States, CBP is involved. According to CBP’s page on importing biological materials, the importer is responsible for compliance, including correct classification, labeling, and documentation, and some materials also need permits from agencies such as USDA or CDC.

Enforcement is active. In a March 2026 release, CBP described officers at the Port of Cincinnati intercepting a shipper in China that attempted to bring in unapproved peptides without clear identification. The lesson for laboratories is practical: vague manifests and generic descriptions draw attention, while specific, truthful documentation is what a legitimate research importer should be able to produce.

For a working checklist, see our guide to peptide imports, COAs, and paperwork that reduce detention risk. At minimum, a research importer should expect to assemble:

The chemical or peptide name, CAS number where one exists, and sequence or identity data
A batch-specific COA showing purity and identity results
A commercial invoice whose description matches the COA
A written statement of the research purpose and the receiving institution
Broker instructions on the FDA disclaimer and the tariff code used

For shipments between U.S. states, CBP and FDA import screening does not apply, but the same documentation habits protect you if a parcel is questioned, delayed, or returned.

Packaging requirements that regulators actually specify

Most physical shipping rules for laboratory materials come from the Department of Transportation’s Hazardous Materials Regulations in 49 CFR Parts 171 to 180. Synthetic lyophilized peptides are generally not infectious substances, so the biological-substance rules are often irrelevant to them. That classification is the shipper’s responsibility, though, and it is worth confirming with a trained hazmat professional rather than assuming.

Where the rules do apply, they are specific. PHMSA’s guide Transporting Infectious Substances Safely explains that Category B packages must be leak-proof, include secondary packaging, carry the UN3373 marking with the proper shipping name, and meet 49 CFR 173.199. The agency also notes that infectious substances were reorganized into two categories, A and B, and that Category B is excepted from some requirements but not from packaging, marking, and handling discipline.

A sound packaging structure for research vials

Whatever the classification, the same layered design reduces loss and contamination risk:

Primary container. A sealed, leak-resistant vial with a tamper-evident closure and a label that matches the COA batch number.
Secondary containment. A sealed bag or tube with absorbent material, so a failed closure does not reach other contents.
Cushioning. Material that prevents vials from contacting each other or the carton walls.
Outer carton. A rigid box rated for the parcel weight, with insulation if the contents are temperature controlled.
Documentation. Packing list and COA inside, shipping label outside, with no marketing language that contradicts the research purpose.

PHMSA has also clarified in an interpretation letter that components from different vendors can be combined, provided the complete integrated system meets the integrity requirements for the material shipped. Mixing a vendor’s insulated shipper with a different supplier’s inner packaging is therefore not a problem in itself, but the assembled package is what must perform.

Dry ice and temperature-controlled shipments

Many laboratories ask for frozen shipment of sensitive compounds. Dry ice is UN1845 and is itself a regulated hazardous material. The PHMSA guidance above states that outer packaging must allow carbon dioxide gas to escape, so a sealed airtight container is not acceptable. PHMSA’s interpretation on Category B substances packed with dry ice addresses how those requirements combine.

Two practical notes from the regulatory record:

Fiberboard cartons need added insulation or liners to manage condensation, because a wet carton loses strength in transit. The USPS Domestic Mail Manual archive makes this point about fiberboard and dry ice. That document is an archived 2007 edition, so treat it as background and check the current mailability standards before relying on it.
Major carriers commonly require a contract or account arrangement to carry dangerous goods, including dry ice, even when the contents are exempt from a full hazardous materials declaration.

If a shipment does not need refrigerant, a validated insulated shipper with a gel pack may be enough, and it avoids the dangerous goods layer entirely. Which approach suits a compound depends on its stability data, a topic we cover in our guide to research-grade peptide formats.

Carrier terms: the contract layer

Carriers set rules beyond federal law. UPS, for example, states in its terms of service that damage arising from the perishable nature of goods falls on the shipper’s side of the ledger. UPS also directs shippers to ensure parcels are correctly marked, packaged, labeled, and documented for dangerous goods, using the carrier’s regional framework. That guide is the German English-language page, so U.S. shippers should confirm against the U.S. service pages.

Three habits protect a lab here:

Read the current terms for perishable and regulated items before the first order, since they change.
Ship early in the week so a parcel does not sit in a facility over a weekend.
Use a delivery address that is staffed. A loading dock or a receiving department with a named contact is more reliable than a general mailbox.

Documentation a receiving lab should expect and keep

A supplier that ships research materials responsibly will include documentation that ties each vial to a batch. We recommend that receiving labs verify and file the following on arrival:

Item	What to check
Certificate of Analysis	Batch number matches the vial label; purity and identity methods are stated; date is present
Packing list and invoice	Product name matches the COA; quantities match the contents
Condition on receipt	Seals intact, no leakage, shipper temperature indicator if one was included
Research purpose record	Principal investigator, project or protocol reference, and storage location
Chain of custody	Who received, who opened, where the material was logged

These records support quality systems as well as compliance. Our guides on regulated peptide handling best practices and risk assessment for research peptide handling describe how to build them into a laboratory procedure, and our vendor evaluation criteria list what to ask a supplier before the first order.

Red flags in supplier shipping practices

Because shipping is where regulators see intent, a supplier’s behavior around it is informative. Be cautious when you see:

Marketing that describes physiological outcomes in people or animals
Peptides sold alongside injection supplies or bacteriostatic water as a kit
No batch-specific COA, or one that cannot be tied to the vial in hand
Generic commodity descriptions such as “research materials” on invoices
Unwillingness to confirm the research purpose or the receiving institution
No stated process for shipment damage, delay, or temperature excursions

FDA’s 2026 warning letter, linked above, shows how these signals are read together. A lab that buys from such a seller inherits some of the scrutiny.

Our perspective

We supply research-use-only peptides, and we think shipping compliance starts earlier than the carrier label. It starts with what a supplier says on its own pages. Our approach rests on three commitments: each compound ships with batch-specific documentation and independent third-party testing, our public content stays on laboratory topics such as analytical testing, storage, and quality control, and we sell to research organizations, laboratories, and qualified research professionals in the United States and Puerto Rico.

We also hold that RUO is a statement of purpose that has to be consistent everywhere. It is not a legal exemption, and we do not present it as one. Our explanation of why peptide compounds are restricted for human use and our legal boundaries guide set out how we think about that line. If a requirement is unclear for your institution, we encourage you to resolve it with your compliance office before ordering.

— Vertex Labs Editorial Team

Ordering for your laboratory

If your team needs documented research materials, our catalog includes peptides, blends, research compounds, and sterile solutions, each with a batch-specific Certificate of Analysis. Institutions can ask about custom peptide sequences and bulk procurement through our main page. For Research Use Only. Not for human or veterinary use.

FAQ

Is there one federal law that regulates shipping research peptides?

No. FDA, CBP, DOT, and the carrier’s own terms each cover a different part of the process. Which ones matter depends on whether the shipment crosses a border, whether it includes dry ice or a regulated biological substance, and how the product is marketed.

Does an RUO label exempt a shipment from FDA rules?

No. FDA’s warning letter shows that the agency looks at marketing, bundling, and messaging, not only the label. Genuine basic research materials can fall outside FDA regulation, but that turns on intended use.

Do research peptides need dry ice?

Not necessarily. The need depends on the stability data for the specific compound and the transit time. When dry ice is used, it is regulated as UN1845 and the package must allow carbon dioxide to vent.

What should I do if a shipment is held or delayed?

Contact the carrier or your customs broker with the COA, invoice, and a statement of research purpose. Your institution’s compliance office should be informed as well. CBP notes that the importer is responsible for classification and documentation, so complete records speed resolution.

Before you enter.